Genio Technologies, Inc.
Tulsa
About Genio Technologies, Inc.
The MasSpec Pen is a handheld pen-like device that rapidly identifies the molecular profile of tissues using a small volume water droplet and mass spectrometry analysis. After 3 seconds of gentle physical contact with a tissue surface, the water droplet is transported to a mass spectrometer, which characterizes diagnostic proteins, lipids, and metabolites. Using machine learning algorithm, a diagnosis is provided with an associate probability of presence of cancer. The pen could be used to rapidly distinguish tumor from healthy tissue during surgery in mice, without requiring specific labeling or imaging and without evidence of tissue destruction. President and CEO: Shannon D. Green
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.2M
- Funding stage: Seed
- Last round: Seed (Jan 2020)
- Website: genio.io
- Phone: [email protected]
Industries & Categories
Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/genio-technologies-inc-172806 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.